Vortioxetine and Duloxetine both come up in the same conversations; they overlap on Serotonin. Vortioxetine: Vortioxetine is an antidepressant used to treat major depressive disorder in adults, often described as a serotonin modulator because it combines several actions on the serotonin system. Duloxetine: Duloxetine is a balanced serotonin-norepinephrine reuptake inhibitor, marketed chiefly as Cymbalta since 2004, approved for major depression and generalized anxiety as well as several chronic pain conditions.
Vortioxetine is an antidepressant used to treat major depressive disorder in adults, often described as a serotonin modulator because it combines several actions on the serotonin system. It both blocks the serotonin transporter, like conventional serotonin reuptake inhibitors, and acts directly on a range of serotonin receptors as an agonist, partial agonist, or antagonist. Approved in the United States and Europe in 2013, it is taken once daily by mouth and has drawn particular interest for possible effects on the cognitive symptoms of depression.
Duloxetine is a balanced serotonin-norepinephrine reuptake inhibitor, marketed chiefly as Cymbalta since 2004, approved for major depression and generalized anxiety as well as several chronic pain conditions. Its analgesic action reflects potentiation of descending serotonergic and noradrenergic pathways that dampen pain signaling in the spinal cord, an effect largely separate from its antidepressant activity. Randomized trials support its use in diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain from osteoarthritis and low back pain, and it is the agent with the strongest randomized evidence recommended by oncology guidelines for chemotherapy-induced peripheral neuropathy. Through the same monoaminergic facilitation of pudendal motor neurons in Onuf's nucleus, duloxetine strengthens urethral sphincter tone and is used in some countries for stress urinary incontinence. It is a prescription-only medicine, available generically, and appears on the World Health Organization list of essential medicines.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
inhibits
inhibits
antagonist
agonist
partial agonist
inhibits
modulates
inhibits
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.